INO Therapeutics Selects Octagon Research Solutions, Inc. To Provide A Foundation For Their eCTD Capability Strategy

Wayne, PA. (February 20, 2007) Chairman and CEO Jim Walker of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced that INO Therapeutics has selected Octagon’s StartingPoint®, eCTD JumpStartTM and ViewPoint® eCTD Complete solutions to launch their eCTD submission capabilities.

Back to news